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GASTROINTESTINAL SENSOR Better clinical outcomes could be obtained if physicians 
IMPLANTATION SYSTEM could obtain continuous readings of the small intestine from 
stationary CEs . Also , in addition to data collection and 
CROSS - REFERENCE TO RELATED image recording , long - term attachment may provide other 
APPLICATIONS 5 possible functions to CE such as tissue manipulation and drug delivery . 
The present application claims the benefit under 35 Since the introduction of wireless capsule endoscopy 
U . S . C . § 119 ( e ) of U . S . Provisional Application Ser . No . ( WCE ) in 2000 , research communities around the world 
61 / 930 , 219 , filed Jan . 22 , 2014 , and titled “ INTUITIVE have been developing miniature swallowable devices that 
SENSOR IMPLANTATION SYSTEM , ” by Benjamin in 10 have potential to replace invasive diagnostic tools . Since the WCE ' s first approval by the Food and Drug Administration Terry . U . S . Provisional Application Ser . No . 61 / 930 , 219 is ( FDA ) in 2001 , capsule technology has evolved to be used incorporated herein by reference in its entirety . by millions and said to be the most effective diagnostic 
GOVERNMENT SUPPORT technique in the small bowel , as well as a subject of 15 worldwide research focused on developing noninvasive 
diagnostic and therapeutic devices . WCEs such as the Pill This invention was made with U . S . government support Cam® SB3 ( Given Imaging Ltd — now Medtronic Inc . , 
under Grant No . NNX10AN62H awarded by the National Minnesota , USA ) ) , MiroCamTM v2 ( IntroMedic Co , Seoul , Aeronautics and Space Administration ( NASA ) . The U . S . South Korea ) are clinically available and have established government has certain rights in this invention . 20 WCE as the gold standard in diagnosing illnesses in the 
small intestine . Technologies such as miniature integrated BACKGROUND circuits ( IC ) and sensors have become readily available , 
which has opened the door for development of miniature 
A capsule endoscope ( CE ) is one of the most common ingestible devices that can replace standard wearable sen 
non - invasive clinical tools in the evaluation of gastrointes - 25 sors . 
tinal ( GI ) tract disease . Currently millions of CEs have been Miniaturizing such technologies and maximizing their 
used worldwide to diagnose the small - bowel and to assess efficacy in a zero gravity environment will be a critical step 
GI tract performance . Specifically , CE intervention has been in pursuing distant space exploration . For example , with the 
adopted when gastroesophageal reflux disease , obscure gas - coming advent of long - distance human space flights , regular 
trointestinal bleeding , Crohn ' s disease , and polyposis syn - 30 monitoring of astronaut health parameters will be critical to 
dromes are indicated . Numerous clinical records and mul - achieve successful and safe missions . The twenty - first cen 
tiple studies have proven that CE intervention is superior to tury has already seen a paradigm shift in medical technol 
radiologic interventions and push endoscopy because it is ogy : groups in both academia and industry are focusing 
non - invasive , has relatively small dimensions , features high research on developing minimally invasive medical devices 
image quality , and provides direct visualization of the tissue . 35 for diagnostics , biopsy , therapeutics , and surgery . In the 
Researchers have been looking to expand this method into 1980 ' s , the National Aeronautics and Space Administration , 
new domains due to increases in chronic diseases and an NASA , took interest in ingestible sensing technologies , a 
aging population . telemetry capsule used for monitoring body core tempera 
In the past , the movement of the CE through the GI tract ture that is now known as the CorTemp® Ingestible Core 
was accepted as being passive and a function of intestine 40 Body Temperature Sensor ( HQ Inc . , Florida , USA ) . The 
peristalsis . However , in order to complete more accurate product of a partnership between the Johns Hopkins Uni 
diagnostics and treatment of chronic diseases , it is desirable versity , the Goddard Space Flight Center , and licensing of 
for CEs to offer controllable locomotion , long - term ( multi - HQ Inc . , the sensor was developed to obtain real time body 
week ) data collection , and drug delivery function . A variety temperature readings of athletes and astronauts for the 
of locomotion systems for CEs have been developed by 45 prevention of heat related illness ( www . spinoffinasa . gov ) . 
different methods such as shape memory alloy legs , mag - Used in a number of applications ranging from monitoring 
netic drive , and earthworm - like locomotive mechanisms . athlete core temperature during training , to sleep studies , to 
The CE ' s capability to acquire long - term physiological monitoring John Glenn ' s temperature during his final days 
indexes is still limited , however , because of its inability to in space , the device is a prime example of the applicability 
remain in - vivo long - term attachment . The gastrointestinal 50 of a swallowable " smart " device . Gant et al . conducted a 
wall is irregular , slippery , chemically corrosive , and physi - study in 2006 involving 10 human subjects who performed 
ologically active due to peristalsis . No traditional technolo - physical exercise while having ingested the CorTemp® 
gies enable effective adhesion to such a surface for a capsule and reported the temperature measurements to be 
prolonged period of time without causing damage or bleed accurate and reliable . Telemetry capsules like the Cor 
ing , and premature loss of the capsule during sensing periods 55 Temp® have been said to be valid tools for assessment of 
has often been reported . Mucosal adhesive patches may be core body temperature . The success of CorTemp® , a sensor 
a potential solution for the long - term attachment require able to gather data for less than 24 hours while passing 
ment , as studied by several research groups . Research through digestive system , suggests that a similar , but much 
groups have shown that high static friction could be created longer duration system could be very useful . 
between a colonoscopic device and the GI wall due to 60 In recent years , the primary need for astronaut health 
mucoadhesion . Mucoadhesive patches have been tested and monitoring is associated with service on board the Interna 
assembled with a release mechanism in the CEs . Addition - tional Space Station ( ISS ) . Astronauts in the ISS have access 
ally , it has been shown that with 5N preload force , 110 min to sensors such as Blood Pressure / Electrocardiographs ( BP / 
stable anchoring could be achieved for a 10 mm diameter ECG ) , Heart Rate Monitor 2 ( HRM2 ) , acoustic dosimeters , 
mucoadhesive patch . These improvements are incremental , 65 Crew Passive Dosimeters ( CPD ) , and a Tissue Equivalent 
however , and still do not enable multi - day or weeks long Proportional Counter ( TEPC ) . The HRM2 is a wearable 
attachment . technology consisting of a watch , transmitter , and chest 
US 10 , 219 , 748 B2 
strap . These devices are assigned to each crew member . The tissue capture device carried by the sensor deployment 
devices record heart rate data which eventually becomes device is being connected to gastrointestinal tissue via 
available for downlink and can be reviewed by flight sur - controlled fluid flow , in accordance with an embodiment of 
geons for diagnosis . The CPD is used to measure radiation the present disclosure . 
exposure and is required to be worn by each member of the 5 FIG . 4C is a schematic view of a tissue capture device 
United States crew , with other countries having their own connected to gastrointestinal tissue within a gastrointestinal 
version of the sensor . Utilizing sensory devices which are lumen of a body , in accordance with an embodiment of the 
worn as straps or carried is not an ideal method of moni present disclosure . 
toring astronaut safety during long term missions . Such FIG . 5A is a schematic view of a control circuit within a devices may inhibit motion , are uncomfortable to wear , 10 sensor deployment device , in accordance with an embodi 
require maintenance , and interfere with daily activities . ment of the present disclosure . 
FIG . 5B is a schematic view of a control circuit within a SUMMARY sensor deployment device , in accordance with an embodi 
A micro - robotic capsule ( MRC ) for implantation of a 15 me is 15 ment of the present disclosure . 
sensor within the gastrointestinal lining of a body is FIG . 6 is a schematic view of a control circuit within a 
described in this disclosure . A system and method are also sensor deployment device inside a body in wireless com 
described in accordance with various implementations of the munication with a second device external to the body , in 
MRC . In one implementation , a sensor deployment device is accordance with an embodiment of the present disclosure . 
embodied by an MRC including an orally - administrable 20 FIG . 7 is a schematic view of a sensor implanted within 
capsule with a tissue capture device removably coupled to a gastrointestinal lumen of a body in wireless communica 
the orally - administrable capsule . The tissue capture device tion with a second device external to the body , in accordance 
includes a plurality of fasteners ( e . g . , micro - needles ) for with an embodiment of the present disclosure . 
connecting the tissue capture device to GI tissue within a FIG . 8 is a schematic view of an orally - administrable 
body . A biometric sensor is coupled to the tissue capture 25 deployment device for implanting sustained release drugs 
device for long term ( e . g . , several days , weeks , or months ( SRDs ) in the intraperitoneal space , in accordance with an 
long ) implantation within the GI tract of the body at the embodiment of the present disclosure . 
attachment site of the tissue capture device . To facilitate the FIG . 9A is a schematic view of an orally - administrable 
attachment to the GI tissue , a chamber within the orally - deployment device for implanting sustained release drugs 
administrable capsule is configured to draw the GI tissue 30 ( SRDs ) in the intraperitoneal space , wherein a tissue capture 
towards the plurality of fasteners when a fluid pressure of the device carried by the deployment device is being connected 
chamber is increased . An actuator is configured to cause an to gastrointestinal tissue via controlled fluid flow , and 
increase of the fluid pressure of the chamber when triggered wherein and SRD is deployed into the intraperitoneal space 
by control circuitry coupled to the actuator . The control via an opening within the tissue capture device , in accor 
circuitry is configured to trigger the actuator at a selected 35 dance with an embodiment of the present disclosure . 
time . For example , the control circuitry can be configured to FIG . 9B is a schematic view of a tissue capture device 
trigger the actuator at a predetermined time associated with connected to gastrointestinal tissue within a gastrointestinal 
the orally - administrable capsule reaching a particular loca - lumen of a body , wherein the tissue capture device reseals an 
tion within the GI tract , such as the small intestine or a incision made in the gastrointestinal tissue for deployment 
particular portion thereof . 40 of an SRD within the intraperitoneal space , in accordance 
This Summary is provided to introduce a selection of with an embodiment of the present disclosure . 
concepts in a simplified form that are further described FIG . 10 is a schematic view of a gastrointestinal pressure 
below in the Detailed Description . This Summary is not sensing device , in accordance with an embodiment of the 
intended to identify key features or essential features of the present disclosure . 
claimed subject matter , nor is it intended to be used as an aid 45 FIG . 11 is a schematic view of a pressure sensor of a 
in determining the scope of the claimed subject matter . gastrointestinal pressure sensing device , in accordance with 
an embodiment of the present disclosure . 
DRAWINGS FIG . 12 is a schematic view of a control circuit for 
detecting ambient and peristaltic gastrointestinal pressure , in 
The detailed description is described with reference to the 50 accordance with an embodiment of the present disclosure . 
accompanying figures . The use of the same reference num - FIG . 13A is a schematic view of a gastrointestinal pres 
bers in different instances in the description and the figures sure sensing device traveling within a gastrointestinal 
may indicate similar or identical items . lumen , in accordance with an embodiment of the present 
FIG . 1 is a schematic view of a sensor deployment device , disclosure . 
in accordance with an embodiment of the present disclosure . 55 FIG . 13B is a schematic view of a gastrointestinal pres 
FIG . 2 is a schematic view of a sensor deployment device , sure sensing device traveling within a gastrointestinal 
in accordance with an embodiment of the present disclosure . lumen , in accordance with an embodiment of the present 
FIG . 3A is a cross - sectional side view of a tissue capture disclosure . 
device , in accordance with an embodiment of the present FIG . 13C is a schematic view of a gastrointestinal pres 
disclosure . 60 sure sensing device traveling within a gastrointestinal 
FIG . 3B is a top view of a tissue capture device , in lumen , in accordance with an embodiment of the present 
accordance with an embodiment of the present disclosure . disclosure . 
FIG . 4A is a schematic view of a sensor deployment FIG . 14 is a schematic view of a sensor deployment 
device within a gastrointestinal lumen of a body , in accor - device , in accordance with an embodiment of the present 
dance with an embodiment of the present disclosure . 65 disclosure . 
FIG . 4B is a schematic view of a sensor deployment FIG . 15 is a flow diagram illustrating an example process 
device within a gastrointestinal lumen of a body , wherein a for deploying a sensor within a gastrointestinal lumen of a 
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body , in accordance with an embodiment of a sensor deploy - replication of this kind of mouth structure is found in the 
ment device such as the sensor deployment device shown in tissue capture device of the sensor deployment device 
FIG . 1 and FIG . 2 . described below . 
FIG . 16 is a flow diagram illustrating an example process 
for deploying a sensor within a gastrointestinal lumen of a 5 Example Implementations 
body , in accordance with an embodiment of a sensor deploy 
ment device such as the sensor deployment device shown in FIGS . 1 through 7 illustrate various embodiments of an 
FIG . 1 and FIG . 2 . orally administrable sensor deployment device 100 . As shown in FIG . 1 , the sensor deployment device 100 includes 
DETAILED DESCRIPTION 10 an orally - administrable capsule 102 ( sometimes referred to herein as an " MRC ” ) with a tissue capture device 104 
removably coupled to the orally - administrable capsule 102 . Overview For example , the tissue capture device 104 can be configured 
to disengage from the orally - administrable capsule 102 after Capsule Endoscopy ( CE ) has been used in medical diag 15 or substantially at the same time as the tissue capture device 
nosis of intestinal diseases such as obscure gastrointestinal 104 is attached to GI tissue at a selected attachment site or bleeding ( OGIB ) . Several kinds of biometric sensors have region within a GI tract of a body . been developed to detect bio - data such as pH , blood glucose , In embodiments , the tissue capture device 104 includes a partial pressure of carbon oxide and temperature etc . in the plurality of fasteners 106 ( e . g . , micro - needles ) for connect 
esophagus and Gastrointestinal ( GI ) tract . These bio - data are 20 ing the tissue capture device 104 to GI tissue . A biometric 
important for diagnosing gastric motility disorder , upper GI sensor 108 may be coupled to or integrated with the tissue 
bleeding , gastro esophagus bleeding , diabetes , and so forth . capture device 104 for long term ( e . g . , several days or weeks 
However , CE technology is limited by the lack of long - term long ) implantation within the GI tract of the body at the 
sensor deployment solutions . Most CE sensors are passive attachment site of the tissue capture device 104 . For 
devices that move through the GI tract by peristalsis and are 25 example , the biometric sensor 108 may include a thermal 
typically cycled out of a subject ’ s body within a day and sensor , a pH sensor , a pressure sensor , an analyte sensor , or 
may only be present in an area of interest ( i . e . , a particular any other deployable , in vivo detector or sensor . FIGS . 3A 
portion of the GI tract ) for several hours at most . There is a and 3B show a cross - sectional view and a top view of the 
need for CE devices that are suitable for long - term ( e . g . , tissue capture device 104 in accordance with an embodiment 
several days or weeks long ) sensor deployment . 30 of this disclosure . As can be seen , the tissue capture device 
Devices . systems , and methods are disclosed below for 104 can include a plurality of fasteners 106 , such as needles , 
long - term GI monitoring . These devices , systems , and meth spikes , hooks , tooth - like structures , or the like . In some 
ods can be useful in high - risk patients or those with recur embodiments , the fasteners 106 are selected with a protrud 
ring afflictions . In implementations , a biometric sensor is ing length ( L ) that is less than a predetermined or estimated 35 thickness of the GI tissue at the selected attachment site or configured for implantation within a GI tract of a body to region of the GI tract . The number of fasteners may be , for monitor several data related with diseases mentioned above example , at least 3 , at least 4 , at least 5 , or at least 6 fasteners such as ambient or peristaltic pressure , pH , temperature , an to enable sufficient anchoring to the GI tissue without 
attribute of one or more analytes ( e . g . , white blood cell causing damage to the tissue at the attachment site . It has 
count , blood glucose , etc . ) , or any other bio - data . As 40 been found that , in some embodiments . 6 fasteners provide 
described in further detail below , a biometric sensor can be sufficient anchoring without any significant damage to the 
deployed to a location within the GI tract via an MRC and attached tissue . The diameter ( D ) of a receiving ( sucker ) 
attached to GI tissue utilizing a tissue capture device that can portion of the tissue capture device should be selected within 
be controllably activated and ejected from the MRC . The a suitable range that is large enough to pull tissue into 
biometric sensor can then collect bio - data and transmit the 45 contact with the fasteners 106 and small enough to enable 
collected data to an externally located device , such as a sufficient suction strength . For example , a diameter ( D ) 
personal computer , smartphone , tablet , notebook , smart - within of approximately 3 to 7 mm may be acceptable for 
watch , external monitoring device , or the like . This data can some applications . It has also been found that , in some 
be directly or indirectly ( e . g . , via a network ) made available embodiments , a diameter in the range of approximately 4 to 
for health service providers . 50 6 mm provides appropriate anchoring for long - term deploy 
Biomimicry has been investigated as a solution for long - ment . It has also been found that the fasteners 106 attach 
term attachment of sensors deployed via orally - adminis - more firmly to GI tissue drawn into the tissue capture 
trable micro - robotic capsules ( MRCs ) . For example , MRCS mechanism 104 when set at certain angles ( O ) , for example , 
designed for sensor deployment are discussed in Tsubaki , A . at angles between 30 and 80 degrees ( e . g . , O = 45° or 609 ) . 
T . , Lewis , W . M . , Terry , B . S . ( 2014 ) . Implantation and 55 The sensor deployment device 100 may further include a 
Carrier Mechanism for Long - Term Biosensing in the Small chamber 110 ( e . g . , a vacuum chamber ) within the orally 
Intestine . J . Med . Devices , 8 ( 3 ) , 030956 - 030956 - 2 and administrable capsule 102 . The chamber 110 may be 
Yang , X . and Terry , B . S . ( 2013 ) . An Anchoring Mechanism vacuum sealed with an internal pressure less than an ambient 
Used to Implant a Biosensor in the Small Intestine . Proc . pressure of the orally administrable capsule 102 . Accord 
ASME . 55607 , Volume 1A , which are hereby incorporated 60 ingly , the chamber 110 can facilitate attachment of the tissue 
by reference in their entirety . Through research , it has been capture device to the GI tissue by drawing the GI tissue 
found that many species of animals and parasites are suc - towards the plurality of fasteners 106 when a fluid pressure 
cessful in attaching to surfaces similar to the lining of the GI of the chamber 110 is increased ( e . g . , by breaking the 
tract for long periods of time . Most of these creatures , such vacuum seal ) . In embodiments , an actuator 112 , such as an 
as the leech , lampreys , and tapeworm , have a similar mouth 65 electromechanically controlled valve or the like , is config 
structure : a combination of hooks and a sucker , that work ured to cause an increase of the fluid pressure of the chamber 
together to achieve the attachment function . A bio - inspired 110 ( e . g . , by letting fluid into the chamber 110 ) when 
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triggered by control circuitry 114 coupled to the actuator most sensors deployed via MRCs are only capable of 
112 . The control circuitry 114 can be powered by a battery collecting data as they travel through the GI tract . 
116 , also located within the orally administrable capsule Embodiments of the control circuitry 114 are illustrated in 
102 , or in some embodiments , by a power generator that is FIGS . 5A and 5B . As shown in FIG . 5A , the control circuitry 
driven by peristaltic forces . The control circuitry 114 can be 5 114 can include a processor 120 ( e . g . , microprocessor or 
configured to trigger the actuator at a selected time , such as microcontroller ) configured to execute program instructions 
a predetermined time that is input by a user prior to 124 from a communicatively coupled storage medium 122 
administering the sensor deployment device 100 and / or ( e . g . , solid - state memory device ) . As shown in FIG . 5B , the 
calculated based upon a determined or estimated location of control circuitry 114 can also include a simple timer circuit 
the sensor deployment device 100 within the GI tract . For 10 126 comprised of discrete components , an ASIC , an FPGA , a PIC , or the like . The control circuitry 114 can be pro example , the control circuitry 114 can be configured to grammed or otherwise configured to trigger the actuator 112 trigger the actuator 112 at a predetermined time associated after a predetermined time from oral administration ( or with the orally - administrable capsule 102 reaching a par activation just prior to being administered ) . The predeter ticular location within the GI tract , such as the small 15 mined time can be input by a user ( e . g . , a health care intestine or a particular portion thereof . In some embodi provider ) and / or calculated based upon one or more attri 
ments , the predetermined time is based upon a GI mapping butes of a subject being treated . In some embodiments , the 
generated utilizing pressure measurements taken at a plu - predetermined time can be based upon a GI mapping spe 
rality of times and locations within the GI tract . For cific to the subject ' s body 200 . For example , the predeter 
example , a mapping can be created using an orally - admin - 20 mined time may be based upon a predetermined or estimated 
istrable pressure sensing device , such as device 400 time required for the sensor deployment device 100 to reach 
described below . In other embodiments , an external suction a selected attachment site within the GI tract 202 of the body 
pressure can be applied at a selected time to a chamber 110 200 . 
within the orally administrable capsule via a suction port 118 Another embodiment is illustrated in FIG . 6 , where the 
( shown in FIG . 2 ) , having substantially the same effect of 25 control circuitry 114 is be coupled with a receiver 128 ( e . g . , 
drawing GI tissue towards the fasteners 106 of the tissue RF receiver , Bluetooth receiver , or the like ) for receiving 
capture device 104 . wireless communications from a second device 300 located 
As illustrated in FIG . 2 , the sensor deployment device 100 external to the body 200 . In some embodiments , the control 
can further include a compressed spring 113 or other ejector circuitry 114 may be configured to receive program instruc 
configured to push the tissue capture device 104 from the 30 tions ( e . g . , timer configurations ) or commands ( e . g . , com 
orally administrable capsule 102 when the tissue capture mands for triggering the actuator 112 ) from the second 
device 104 is attached to GI tissue . The tissue capture device device 300 . Examples of the second device 300 can include 
104 may be couple into snug fittings of the orally adminis - a personal computer , notebook , tablet , a smartphone , smart 
trable capsule 102 . In some embodiments , O - rings or rubber watch , or the like . In some embodiments , control circuitry 
washers may be used to create a snug interface between the 35 114 may be further configured to communicate data ( e . g . , via 
capsule fittings and interfacing portions of the tissue capture an RF transmitter ) to the second device 300 . For example , 
device 104 . The interface should hold the tissue capture the control circuitry 114 may communicate location data or 
device 104 and the orally administrable capsule 102 together biometric data collected from other sensors within the sensor 
tightly until the tissue capture device 104 is ejected from the deployment device 100 . In some embodiments , the control 
orally administrable capsule 102 . In some embodiments , 40 circuitry 114 may receive program instructions or com 
rather than being forcefully ejected , the orally administrable mands from the second device 300 based upon data com 
capsule 102 may simply be pulled away from the tissue municated to the second device 300 . For example , the 
capture device 104 by peristaltic forces after the tissue second device 300 may send a command for triggering the 
capture device 104 has been attached to GI tissue . actuator 112 in response to receiving data indicating that the 
FIGS . 4A through 4C illustrate an embodiment of the 45 sensor deployment device 100 may have reached the 
sensor deployment device 100 traveling through a GI tract selected attachment site or in response to receiving biomet 
202 of a body 200 . FIG . 4A illustrates the sensor deployment ric data that suggests further monitoring would be beneficial 
device 100 , fully intact , traveling through a lumen of the GI at a location of the sensor deployment device 100 . 
tract 202 . The sensor deployment device 100 is configured As shown in FIG . 7 , once the tissue capture device 104 is 
to travel passively through the GI tract 202 via peristaltic 50 implanted within the body 200 by attachment of the tissue 
forces . As discussed above , the control circuitry 114 can be capture device 104 to a luminal wall of the GI tract 202 , the 
configured to trigger an actuator 112 to cause fluid flow into biometric sensor 108 can collect data ( e . g . , pressure mea 
the chamber 110 located inside the orally administrable surements , temperature , pH , presence / absence or other attri 
capsule 102 . FIG . 4B shows how , as a result of the fluid flow butes for one or more analytes , etc . ) . For example , the 
into the chamber 110 , GI tissue 204 is drawn towards the 55 biometric sensor 108 may collect data continuously , peri 
fasteners 106 of the tissue capture device 104 . The tissue odically , or in response to one or more requests received 
capture device 104 is then attached to a luminal wall of the from an external device 300 . A transmitter 130 ( e . g . , RF 
GI tract 202 , and the remainder of the orally administrable transmitter ) coupled to the biometric sensor 108 may facili 
capsule 102 disengages from the tissue capture device 104 tate communication of the sensor data to the external device 
and is eventually removed from the body 200 by peristaltic 60 300 . In some embodiments , the biometric sensor 108 can 
forces . The biometric sensor 108 is thus implanted within also be coupled to a receiver ( e . g . , RF receiver ) for receiving 
the GI tract 202 until the connection between the tissue program instructions or commands ( e . g . , data requests ) from 
capture device 104 and the GI tissue 204 wears away due to the external device 300 . 
continued cell growth and peristalsis . Using the tissue cap - Many different kinds of biometric sensors 108 can be 
ture device 104 to implant the biometric sensor 108 may 65 deployed via the sensor deployment device 100 for various 
enable multiple day and possibly multiple week long sensing health monitoring applications . Some health monitoring 
periods at selectable sites within the GI tract 202 ; whereas , applications are concerned with continuous or periodic 
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detection for risk indicators ( e . g . , GI bleeding , temperature over time that the pressure sensing device 400 travels 
or pH inconsistency , pressure changes , etc . ) . However , other through the body , an expected , baseline model ( e . g . , nominal 
applications can include GI monitoring for general health GI map ) can be modified to generate a GI mapping for the 
applications , such as weight management . In some embodi - body 200 . For example , an average rate of motion can be 
ments , for example , the biometric sensor 108 can include a 5 identified for the body or for particular portions of the GI 
flow sensor configured to detect a volumetric flow rate at the tract ( e . g . , rate of motion within the small intestine ) , 
attachment site within the GI tract ( e . g . , flow rate through detected pressure changes can be used to determine passage 
the small intestine ) . The volumetric flow rate can be moni - of the pressure sensing device 400 from one portion of the 
tored with data ( e . g . , user - input data ) about food intake to GI tract to another ( e . g . , entering the small intestine ) , and so 
characterize a subject ' s metabolic profile and provide indi - 10 forth . As shown in FIG . 10 , the pressure sensing device 400 
vidualized dietary recommendations ( e . g . , quantity and / or can include an orally administrable capsule 402 with at least 
quality of food recommendations , a measure of " fullness , " two pressure sensors 404 embedded in the surface of the 
etc . ) . This information can be used for long term weight loss capsule 402 . In the embodiment shown in FIG . 10 , the 
assistance and may be helpful in identifying behavioral pressure sensing device 400 includes at least a first sensor 
defects . For example , individuals that continue to consume 15 404 located at an end of the orally administrable capsule 402 
food after reaching a generally accepted level of “ fullness ” and at least a second sensor 404 located at a lateral surface 
may suffer from certain eating disorders that require psy - or side portion of the orally administrable capsule 402 . 
chiatric intervention . The foregoing example illustrates one A s shown in FIG . 11 , each pressure sensor 404 can 
possible application of long - term GI sensor deployment include a transducer 410 that ultimately receives ambient 
Those skilled in the art will further appreciate that the sensor 20 and / or peristaltic forces and generates a corresponding elec 
deployment device 100 has utility in many other applica - trical signal . A variety of designs may be employed to 
tions where long - term GI monitoring is required or helpful . enhance sensitivity of the transducer 410 . For example , each 
Looking now to FIG . 8 , another embodiment of the pressure sensor 404 can include a button coupled to an 
deployment device 100 is shown for deployment of a aluminum beam that deforms and affects the transducer 410 
sustained release drug ( SRD ) 134 instead of or in addition to 25 when pressure is applied to the button . In the embodiment 
the biometric sensor 108 . In some embodiments , the deploy shown in FIG . 11 , each pressure sensor 404 includes a 
ment device 100 may include a catheter 132 located within rubber sheet 406 formed over the transducer 410 with a 
the orally administrable capsule 102 . The catheter 132 may silicon oil 408 filling the space in between . Thus , when the 
be configured to puncture the luminal wall of the GI tract rubber sheet 406 is pressed down by ambient or peristaltic 
202 upon attachment of the tissue capture device 104 to 30 forces , the transducer 410 is affected by the resulting defor 
facilitate deployment of the SRD 134 within the intraperi mation of the silicon oil 408 in between the rubber sheet 406 
toneal space of the body 200 . For example , FIG . 9A shows and the transducer 410 . Those skilled in the art will appre 
the catheter puncturing a portion of GI tissue that is drawn ciate that additional designs may be employed to achieve 
into the tissue capture device 104 towards the fasteners 106 . requisite sensitivity of the pressure sensors 404 for detecting 
Upon puncturing the GI tissue , the catheter 132 may be 35 ambient and peristaltic pressures within the GI tract 202 of 
configured to release the SRD 134 into the intraperitoneal a body 200 . 
space of the body 200 . The tissue capture device 104 can FIG . 12 shows an embodiment of circuitry within the 
include a suture mechanism ( e . g . , bio - compatible adhesive orally - administrable capsule 402 for processing the pressure 
or staples ) to close the incision made by the catheter 132 or sensor 404 outputs and relaying the collected pressure 
may simply be configured to apply pressure at the attach - 40 measurements to an external device 300 . In some embodi 
ment site to close the incision until the GI tissue sufficiently ments , the transducer 410 of each pressure sensor 404 is 
heals . For example , FIG . 9B shows the tissue capture device coupled to or comprises a leg of a Wheatstone bridge . 
104 closing the incision made by the catheter 132 after the Embodiments of pressure sensor circuity and other design 
SRD 134 has been deployed within the intraperitoneal features are described in further detail in Li , P . and Terry , B . 
space . 45 S . ( 2014 ) . Design of a Swallowable Microrobotic Capsule 
As mentioned above , the timing for attachment of the for Measuring Small Intestine Pressure . J . Med . Devices , 
tissue capture device 104 and corresponding deployment of 8 ( 3 ) , 030910 - 030910 - 2 , which is incorporated herein by 
the biometric sensor 108 and / or SRD 134 may be controlled reference in its entirety . The pressure detected by each of the 
in accordance with a predetermined GI mapping of the body sensors 404 affects a resistance value ( e . g . , Ros , or R ) of 
200 . For example , the control circuitry 114 can be config - 50 the corresponding leg of the Wheatstone bridge . Typically , 
ured to trigger the actuator 112 for attachment of the tissue peristaltic pressure ( i . e . , pressure due to the luminal walls 
capture device 104 to the luminal wall of the GI tract 202 pressing on the capsule 402 ) will be experienced at one of 
based upon an expected position of the sensor deployment the pressure sensors 404 or at none of them . Some example 
device 100 within the GI tract 202 . Because each body has scenarios are shown in FIGS . 13A through 13C . At narrower 
a somewhat unique peristalsis cycle , a body - specific GI 55 luminal passages ( e . g . , in the small intestine ) , peristaltic 
mapping can assist in optimizing deployment timing and pressure is likely to be detected by the pressure sensor 404 
thus being able to effectively deploy the tissue capture located at the side portion of the capsule 402 ( e . g . , as shown 
device 104 at an attachment site suitable for long - term in FIG . 13A ) . At wider luminal passages , peristaltic pressure 
anchoring , biometric measurements , and / or SRD deploy - is likely to be detected by the pressure sensor 404 located at 
ment . To facilitate a body - specific GI mapping , another 60 the end of the capsule 402 ( e . g . , as shown in FIG . 13B ) or 
MRC can be used in a two - pill GI mapping and deployment by neither one of the pressure sensors ( e . g . , as shown in FIG . 
system . 13C ) . The voltage or current detected across two nodes of 
An embodiment of an orally administrable pressure sens - the Wheatstone bridge can be analyzed to determine which 
ing device 400 is shown in FIG . 10 . The pressure sensing sensor ( if any ) is detecting the most pressure , the amount of 
device 400 can be used to collect ambient and peristaltic 65 pressure detected , and so forth . In some embodiments , the 
pressures at a plurality of times and locations throughout the Wheatstone bridge ' s nodal outputs are coupled to an ampli 
GI tract 202 of a body 200 . Using the pressure data collected fier ( e . g . , an Op - Amp ) or other pre - processing front - end 
11 
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circuitry . The output is then fed into a control circuit 414 , device 300 for external control of the sensor deployment 
such as a processor , microcontroller , ASIC , FPGA , or the device 100 or simply for additional ( non - stationary ) moni 
like , and communicated via a transmitter 416 ( e . g . , RF i toring of the GI tract . 
transmitter ) to an external device 300 that records the 
measured pressures over time . Example Processes 
The external device 300 can further be configured to 
adjust a baseline model according to the received measure - FIGS . 15 and 16 illustrate example processes 500 and 
ments . For example , the external device 300 can determine 600 , respectively . Processes 500 and 600 can be manifested 
a location of the pressure sensing device 400 within the GI by the systems and devices described above ( e . g . , device 
tract 202 of the body 200 with higher accuracy by using the 10 100 , device 300 , and / or device 400 ) and can include one or 
pressure measurements to determine how far from an more steps or processing blocks for carrying out one or more 
expected ( nominal ) location the pressure sensing device 400 of the functions or operations described above . However , 
is located . Thus , the external device 300 can generate a processes 500 and 600 are not limited to the system and 
body - specific model that takes actual peristalsis character device embodiments described herein and may alternatively 
istics of the body into account . In some embodiments , the 15 be manifested by any combination of components suitable 
control circuitry 414 of the pressure sensing device 400 for carrying out the methodology described below . 
further includes or is coupled to a receiver ( e . g . , RF flow diagram in FIG . 15 illustrates a method 500 of 
receiver ) . The control circuitry 414 can be further configured deploying a sensor in a GI tract of a body . At step 502 , a 
to send signals to and / or receive triangulation signals from sensor deployment device ( e . g . , device 100 ) is orally admin 
at least two sources ( e . g . , external devices 300 ) having 20 istered to a subject . For example , the subject may be directed 
known locations relative to the body 200 . Based upon the to swallow an MRC ( e . g . , capsule 102 ) including a remov 
triangulation signals , the location of the pressure sensing able tissue capture device ( e . g . , device 104 ) with a biometric 
device 400 can also be found . Triangulation can be useful , sensor ( e . g . , sensor 108 ) integrated therewith or coupled 
for example , when the pressure sensors 404 become inactive thereto and a plurality of fasteners for connecting to GI 
or exhibit unusual readings . In such cases , it can be useful 25 tissue within the GI tract of the subject ' s body . At a selected 
to know whether the pressure sensing device 400 has time , the method 500 proceeds to step 504 , wherein the 
become stuck or defective . Additionally , triangulation can be tissue capture device is attached to a luminal wall of the GI 
used to eliminate the need for a baseline model . For tract . For example , GI tissue from the luminal wall may be 
example , triangulation - based positioning and pressure mea drawn in towards fasteners ( e . g . , fasteners 106 ) of the tissue 
surements collected over time can be used to generate a GI 30 capture device by fluid flow directed into a vacuum chamber 
mapping for the body . ( e . g . , chamber 110 ) . In some embodiments , fluid may flow 
In some embodiments , the sensor deployment device 100 into the chamber when the chamber is opened by an actuator 
may include certain features of the pressure sensing device ( e . g . , actuator 112 ) . After or at substantially the same time as 
400 , and vice versa . FIG . 14 shows an embodiment , for the tissue capture device is attached to the GI tissue , the 
example , where the sensor deployment device 100 includes 35 tissue capture device is disengaged from the MRC . The 
pressure sensors 140 substantially similar or identical to the MRC continues to move through the body while the tissue 
pressure sensors 404 described above . The control circuitry capture device remains implanted at the attachment site of 
114 may be configured to communicate pressures collected the GI tract . At step 506 , data can be received from the 
at a plurality of locations and times to the external device biometric sensor at a second device ( e . g . , device 300 ) 
300 . The control circuitry 114 may receive a command or 40 located outside of the body . For example , the biometric 
request from the external device 300 to deploy the tissue sensor can transmit data to the second device continuously , 
capture device 104 when the pressure measurements and periodically , according to a predetermined schedule , when a 
timing are consistent with a selected attachment site within biometric threshold ( e . g . , threshold temperature ) is 
the GI tract . Alternatively , the control circuitry 114 of the breached , or in response to a command or request received 
sensor deployment device 100 , on its own , may be config - 45 from the second ( externally located ) device . Biometric data 
ured to determine when it has reached an appropriate can be collected until the tissue capture device detaches 
attachment site within the GI tract based upon time and from the luminal wall of the GI tract , perhaps days or 
pressure data . For example , the actuator 112 may be trig - possibly weeks later , due to cellular growth and / or peristal 
gered to deploy the tissue capture device 104 after a prede - sis . 
termined time period , only when a certain pressure threshold 50 FIG . 16 shows another flow diagram illustrating a method 
or range is reached . 600 of generating a GI mapping for a body and deploying a 
In some embodiments , the sensor deployment device 100 sensor in a GI tract of the body . At step 602 , a pressure 
may include additional location , orientation , or motion sen - sensing device ( e . g . , device 400 ) is orally administered to a 
sors to assist with location determination of the sensor subject . For example , the subject may be directed to swallow 
deployment device 100 within the GI tract . For example , the 55 an MRC ( e . g . , capsule 402 ) including one or more pressure 
sensor deployment device 100 can further include an inertial sensors 404 . The pressure sensing device may passively 
measurement unit , such as a multiple - axis ( e . g . , three - axis ) travel through the GI tract of the subject ' s body and collect 
accelerometer 136 and / or a gyroscope 138 , coupled to the pressure measurements at a plurality of locations and times . 
control circuitry 114 or a pH sensor . Inertial data , pH For example , the pressure sensing device may collect pres 
measurements , and / or pressure measurements can be used 60 sure measurements substantially continuously , periodically , 
along with timing data to pinpoint the location of the sensor or according to a schedule . The pressure sensing device may 
deployment device 100 within the GI tract . The control communicate the collected pressure measurements to a 
circuity 114 can use any combination of sensor data along second device ( e . g . , device 300 ) located outside of the body . 
with timing data to determine an appropriate time for At step 604 , a GI mapping can be generated with the 
deployment of the tissue capture device 104 . Additionally , 65 collected pressure measurements . For example , a model of 
sensor data ( e . g . , inertial , pH , or pressure data ) can be expected MRC locations within the GI tract at certain times 
transmitted ( e . g . , via an RF transmitter ) to the external can be adjusted according to the pressure measurements . 
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Because certain pressure levels or changes can indicate that are various embodiments by which systems and methods 
the MRC has entered or left certain portions of the GI tract , described herein can be implemented , and that the imple 
the measurements can be used to pinpoint the actual location mentation will vary with the context in which an embodi 
of the MRC and the model can be adjusted to compensate ment of the disclosure is deployed . 
from a deviation between the actual location and the 5 Furthermore , it is to be understood that the invention is 
expected location of the MRC . In some embodiments , defined by the appended claims . Although embodiments of triangulation data can also be used to determine a location of this invention have been illustrated , it is apparent that the MRC . After a GI mapping has been generated , the various modifications may be made by those skilled in the method 600 can proceed to step 606 , where a sensor art without departing from the scope and spirit of the deployment device ( e . g . , device 100 ) is orally administered 10 disclosure . to the subject . At a selected time , the method 600 proceeds 
to step 604 , wherein a tissue capture device ( e . g . , device 
104 ) carried by the sensor deployment device is attached to What is claimed is : 
a luminal wall of the GI tract . The selected time may be 1 . A sensor deployment device , comprising : 
based upon the GI mapping generated with the orally 15 an orally - administrable capsule ; 
administered pressure sensing device . For example , the a tissue capture device removably coupled to the orally 
selected time may be associated with a predetermined period administrable capsule , the tissue capture device includ 
of time required for an MRC ( e . g . , device 100 or device 400 ) ing a plurality of fasteners for connecting the tissue 
to reach a particular site within the GI tract ( e . g . , the small capture device to gastrointestinal tissue within a gas 
intestine or a particular portion thereof ) . After or at substan - 20 trointestinal tract of a body ; 
tially the same time as the tissue capture device is attached a biometric sensor coupled to the tissue capture device ; 
to the GI tissue , the tissue capture device is disengaged from a chamber within the orally - administrable capsule , the 
the remainder of the sensor deployment MRC . The remain chamber being configured to draw gastrointestinal tis 
der of the MRC continues to move through the body while sue towards the plurality of fasteners when a fluid 
the tissue capture device remains implanted at the attach - 25 pressure of the chamber is increased ; 
ment site of the GI tract . At step 606 , data can be received an actuator configured to cause an increase of the fluid 
from the biometric sensor at a second device ( e . g . , device pressure of the chamber ; and 
300 ) located outside of the body . For example , the biometric control circuitry coupled to the actuator , the control 
sensor can transmit data to the second device continuously , circuitry being configured to trigger the actuator to 
periodically , according to a predetermined schedule , when a 30 cause the increase of the fluid pressure of the chamber 
biometric threshold ( e . g . , threshold temperature ) is at a selected time , 
breached , or in response to a command or request received wherein the tissue capture device is configured to detach 
from the second ( externally located ) device . Biometric data from the orally - administrable capsule , and 
can be collected until the tissue capture device detaches wherein the biometric sensor remains coupled to the 
from the luminal wall of the GI tract , perhaps days , weeks , 35 tissue capture device after the tissue capture device 
or possibly months later , due to cellular growth and / or detaches from the orally - administrable capsule . 
peristalsis . 2 . The sensor deployment device of claim 1 , wherein the 
It should be recognized that the various functions , opera - control circuitry includes a processor in communication with 
tions , blocks , or steps described throughout the present a storage medium , the storage medium bearing program 
disclosure may be carried out by any combination of hard - 40 instructions that are executable by the processor . 
ware , software , or firmware . In some embodiments , various 3 . The sensor deployment device of claim 1 , wherein the 
steps or functions are carried out by one or more of the control circuitry includes a timer circuit . 
following : electronic circuitry , logic gates , multiplexers , a 4 . The sensor deployment device of claim 1 , wherein the 
programmable logic device , an application - specific inte selected time is based upon a gastrointestinal mapping . 
grated circuit ( ASIC ) , a controller / microcontroller , or a 45 5 . The sensor deployment device of claim 4 , wherein the 
computing system . A computing system may include , but is gastrointestinal mapping is derived from pressure data col 
not limited to , a personal computing system , mainframe lected by a second orally - administrable capsule at a plurality 
computing system , workstation , image computer , parallel of times and a plurality of locations within the gastrointes 
processor , or any other device known in the art . In general , tinal tract of the body . 
the terms " controller ” and “ computing system ” are broadly 50 6 . The sensor deployment device of claim 1 , further 
defined to encompass any device having one or more comprising : 
processors , which execute instructions from a carrier a radio frequency ( RF ) receiver coupled with the control 
medium . circuitry , wherein the selected time for triggering the 
Program instructions implementing methods , such as actuator is based upon a communication received , via 
those manifested by embodiments described herein , may be 55 the RF receiver , from a second device located external 
transmitted over or stored on carrier medium . The carrier to the body . 
medium may be a transmission medium , such as , but not 7 . The sensor deployment device of claim 1 , further 
limited to , a wire , cable , or wireless transmission link . The comprising : 
carrier medium may also include a non - transitory signal a radio frequency ( RF ) transmitter coupled with the 
bearing medium or storage medium such as , but not limited 60 biometric sensor , the RF transmitter being configured 
to , a read - only memory , a random access memory , a mag to communicate data from the biometric sensor to a 
netic or optical disk , a solid - state or flash memory device , or second device located external to the body . 
a magnetic tape . 8 . The sensor deployment device of claim 1 , wherein each 
It is further contemplated that any embodiment of the fastener of the plurality of fasteners is disposed at an angle 
disclosure manifested above as a system or method may 65 ranging between thirty degrees and eighty degrees with 
include at least a portion of any other embodiment described respect to an axis that is perpendicular to a top surface of the 
herein . Those having skill in the art will appreciate that there tissue capture device . 
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9 . A sensor deployment device , comprising : an orally - administrable capsule ; 
an orally - administrable capsule ; a tissue capture device removably coupled to the orally 
a tissue capture device removably coupled to the orally administrable capsule , the tissue capture device 
administrable capsule , the tissue capture device includ including a plurality of fasteners for connecting the 
ing a plurality of fasteners for connecting the tissue 5 tissue capture device to gastrointestinal tissue within a body ; and capture device to gastrointestinal tissue within a body ; a biometric sensor coupled to the tissue capture device ; a biometric sensor coupled to the tissue capture device ; and 
a chamber within the orally - administrable capsule , the causing the tissue capture device to , at a selected time , 
chamber being configured to draw gastrointestinal tis connect to gastrointestinal tissue within a gastrointes 
sue towards the plurality of fasteners when a fluid " tinal tract of the body , 
pressure of the chamber is increased ; wherein the tissue capture device is configured to detach 
an actuator configured to cause an increase of the fluid from the orally - administrable capsule , and 
pressure of the chamber ; and wherein the biometric sensor remains coupled to the 
control circuitry coupled to the actuator , the control tissue capture device after the tissue capture device 
circuitry being configured to trigger the actuator to detaches from the orally - administrable capsule . 
cause the increase of the fluid pressure of the chamber 15 . The sensor deployment method of claim 14 , wherein 
at a selected time , the selected time being based upon the selected time is based upon a predetermined time inter 
a gastrointestinal mapping derived from pressure data 
collected by a second orally - administrable capsule at a 20 16 . The sensor deployment method of claim 15 , wherein 
plurality of times and a plurality of locations within a 20 the predetermined time interval is based upon a gastrointes 
gastrointestinal tract of the body , tinal mapping . 
wherein the biometric sensor remains coupled to the 17 . The sensor deployment method of claim 16 , wherein 
tissue capture device after the tissue capture device the gastrointestinal mapping is derived from pressure data 
detaches from the orally - administrable capsule . collected by a second orally - administrable capsule at a 
10 . The sensor deployment device of claim 9 , wherein the 25 plurality of times and a plurality of locations within the P 
control circuitry includes a processor in communication with gastrointestinal tract of the body . 
a storage medium , the storage medium bearing program 18 . The sensor deployment method of claim 14 , further 
instructions that are executable by the processor . comprising : 
11 . The sensor deployment device of claim 9 , wherein the 30 receiving data from the biometric sensor with a second 
control circuitry includes a timer circuit . O device located external to the body . 
12 . The sensor deployment device of claim 9 , further 19 . The sensor deployment method of claim 18 , wherein the data received from the biometric sensor includes at least comprising : 
a radio frequency ( RF ) transmitter coupled with the one of a detected pressure , a detected pH , a detected 
biometric sensor , the RF transmitter being configured 35 temperature , or a detected attribute of an analyte . 
to communicate data from the biometric sensor to a 35 20 . The sensor deployment method of claim 14 , wherein 
second device located external to the body . causing the tissue capture device to connect to gastrointes 
13 . The sensor deployment device of claim 9 , wherein the tinal tissue within the body comprises : 
collected pressure data includes ambient pressure measure causing fluid to flow into a chamber positioned relative to the tissue capture device such that the gastrointestinal 
ments . 
14 . A sensor deployment method , comprising : tissue is drawn towards the fasteners of the tissue 
orally administrating a sensor deployment device , the capture device . 
sensor deployment device including : 
40 
